Related Experiment Videos
The relationship between airways inflammation and asthma severity
American Journal of Respiratory and Critical Care Medicine
|January 5, 2000
Summary
Persistent asthma involves ongoing airway inflammation from eosinophils, mast cells, and neutrophils, even with corticosteroid treatment. This inflammation correlates with asthma severity and specific biomarkers.
Area of Science:
- Pulmonary Medicine
- Immunology
- Allergy
Background:
- Asthma is a chronic respiratory disease characterized by airway inflammation.
- Understanding the relationship between inflammation and disease severity is crucial for managing persistent asthma.
- Current treatment guidelines classify asthma severity based on established criteria.
Purpose of the Study:
- To investigate the link between airway inflammation and asthma severity.
- To enhance the understanding of persistent asthma.
- To identify inflammatory mediators and cell types involved in asthma.
Main Methods:
- Studied 74 asthmatics across different severity levels and 22 nonatopic controls.
- Utilized induced sputum analysis for cell counts and inflammatory mediators (albumin, ECP, MPO, tryptase).
- Assessed asthma severity using FEV(1), PEF variability, symptom scores, and methacholine responsiveness.
Main Results:
- Sputum eosinophilia and ECP levels correlated with asthma severity and responsiveness.
- Neutrophilia and MPO showed weak correlations with PEF variability and symptoms.
- Elevated tryptase in mild-to-moderate asthma; raised albumin across all severities, correlating with tryptase and ECP.
- Prominent eosinophilic inflammation persisted despite corticosteroid treatment.
Conclusions:
- Airway inflammation in persistent asthma involves eosinophils, mast cells, and neutrophils.
- Inflammation is linked to disease severity and persists despite corticosteroid therapy.
- Biomarkers like ECP and albumin are indicative of inflammatory processes in asthma.